BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 20203504)

  • 1. Bacterial flora in inflammatory bowel disease.
    Marteau P
    Dig Dis; 2009; 27 Suppl 1():99-103. PubMed ID: 20203504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Intestinal flora and Crohn's disease].
    Desreumaux P; Colombel JF
    Ann Pharm Fr; 2003 Jul; 61(4):276-81. PubMed ID: 12843962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Gut microbiota and IBD].
    Seksik P
    Gastroenterol Clin Biol; 2010 Sep; 34 Suppl 1():S44-51. PubMed ID: 20889004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influences of intestinal bacteria in human inflammatory bowel disease.
    Vanderploeg R; Panaccione R; Ghosh S; Rioux K
    Infect Dis Clin North Am; 2010 Dec; 24(4):977-93, ix. PubMed ID: 20937461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nucleotide-binding-oligomerization domain proteins and toll-like receptors: sensors of the inflammatory bowel diseases' microbial environment.
    Mueller T; Podolsky DK
    Curr Opin Gastroenterol; 2005 Jul; 21(4):419-25. PubMed ID: 15930981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enteric bacteria, lipopolysaccharides and related cytokines in inflammatory bowel disease: biological and clinical significance.
    Caradonna L; Amati L; Magrone T; Pellegrino NM; Jirillo E; Caccavo D
    J Endotoxin Res; 2000; 6(3):205-14. PubMed ID: 11052175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacteria as trigger for chronic gastrointestinal disorders.
    Marteau P; Chaput U
    Dig Dis; 2011; 29(2):166-71. PubMed ID: 21734380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fungi and inflammatory bowel diseases: Alterations of composition and diversity.
    Ott SJ; Kühbacher T; Musfeldt M; Rosenstiel P; Hellmig S; Rehman A; Drews O; Weichert W; Timmis KN; Schreiber S
    Scand J Gastroenterol; 2008; 43(7):831-41. PubMed ID: 18584522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular analysis of the bacterial microbiota in duodenal biopsies from dogs with idiopathic inflammatory bowel disease.
    Suchodolski JS; Xenoulis PG; Paddock CG; Steiner JM; Jergens AE
    Vet Microbiol; 2010 May; 142(3-4):394-400. PubMed ID: 19959301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review article: the role of bacteria in onset and perpetuation of inflammatory bowel disease.
    Seksik P; Sokol H; Lepage P; Vasquez N; Manichanh C; Mangin I; Pochart P; Doré J; Marteau P
    Aliment Pharmacol Ther; 2006 Oct; 24 Suppl 3():11-8. PubMed ID: 16961738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prebiotics in inflammatory bowel diseases.
    Guarner F
    Br J Nutr; 2007 Oct; 98 Suppl 1():S85-9. PubMed ID: 17922967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbiota in pediatric inflammatory bowel disease.
    Schwiertz A; Jacobi M; Frick JS; Richter M; Rusch K; Köhler H
    J Pediatr; 2010 Aug; 157(2):240-244.e1. PubMed ID: 20400104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacteriotherapy for inflammatory bowel disease: therapeutic tool and/or pharmacological vectors?
    Marteau P; Sokol H; Dray X; Seksik P
    Gastroenterol Clin Biol; 2009 Jun; 33 Suppl 3():S228-34. PubMed ID: 20117346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microbiota of de-novo pediatric IBD: increased Faecalibacterium prausnitzii and reduced bacterial diversity in Crohn's but not in ulcerative colitis.
    Hansen R; Russell RK; Reiff C; Louis P; McIntosh F; Berry SH; Mukhopadhya I; Bisset WM; Barclay AR; Bishop J; Flynn DM; McGrogan P; Loganathan S; Mahdi G; Flint HJ; El-Omar EM; Hold GL
    Am J Gastroenterol; 2012 Dec; 107(12):1913-22. PubMed ID: 23044767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD40 and CD86 upregulation with divergent CMRF44 expression on blood dendritic cells in inflammatory bowel diseases.
    Vuckovic S; Florin TH; Khalil D; Zhang MF; Patel K; Hamilton I; Hart DN
    Am J Gastroenterol; 2001 Oct; 96(10):2946-56. PubMed ID: 11693331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucosa-associated Faecalibacterium prausnitzii and Escherichia coli co-abundance can distinguish Irritable Bowel Syndrome and Inflammatory Bowel Disease phenotypes.
    Lopez-Siles M; Martinez-Medina M; Busquets D; Sabat-Mir M; Duncan SH; Flint HJ; Aldeguer X; Garcia-Gil LJ
    Int J Med Microbiol; 2014 May; 304(3-4):464-75. PubMed ID: 24713205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacteria in the pathogenesis of inflammatory bowel disease.
    Subramanian S; Campbell BJ; Rhodes JM
    Curr Opin Infect Dis; 2006 Oct; 19(5):475-84. PubMed ID: 16940872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory bowel disease, gut bacteria and probiotic therapy.
    Reiff C; Kelly D
    Int J Med Microbiol; 2010 Jan; 300(1):25-33. PubMed ID: 19800289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review article: gut flora and inflammatory bowel disease.
    Marteau P; Lepage P; Mangin I; Suau A; Doré J; Pochart P; Seksik P
    Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 4():18-23. PubMed ID: 15352889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aetiology of inflammatory bowel disease (IBD): role of intestinal microbiota and gut-associated lymphoid tissue immune response.
    Thompson-Chagoyán OC; Maldonado J; Gil A
    Clin Nutr; 2005 Jun; 24(3):339-52. PubMed ID: 15896420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.